Gapping up
In reaction to earnings/guidance:
- AA +6.5% (also initiates dividend; announces $500 mln share repurchase program), JBHT +3.6%, WAFD +1.8%, SXT +0.5%
Other news:
- BTCM +10.2% (BTC.com to exit China)
- ME +9% (positive mention on CNBC)
- LVTX +8.1% (granted orphan drug designation for the company's CD1d targeted Gammabody LAVA-051)
- MRNA +3.2% (confirms that FDA Advisory Committee unanimously votes in support of emergency use for a booster dose)
- ML +2.2% (stock offering)
- FUBO +1.8% (announces partnership with NASCAR)
- PENN +1.5% (SCR receives court approval to be acquired by PENN)
- SCR +1.5% (SCR receives court approval to be acquired by PENN)
- IONS +1.4% (in sympathy with BIIB news)
- STLD +1.3% (to acquire minority interest in New Process Steel)
- AZN +1.1% (reports Imfinzi plus tremelimumab HIMALAYA Phase III trial met primary endpoint)
Analyst comments:
- FLS +1.9% (upgraded to Buy from Neutral at UBS)